VeriMomtripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 hamilelikte güvenli mi?
No harmonised CLP reproductive classifications (ECHA Annex VI) or CIR/SCCS safety opinions listing reproductive hazard for these cosmetic peptides. Peer‑reviewed and regulatory sources for cosmetic peptides (e.g., oligopeptides/dipeptides/tripeptides used in topical products) do not report teratogenicity or reproductive toxicity; large peptide size and intended topical use make systemic reproductive hazard unlikely (sources: ECHA Annex VI — no harmonised H360/H361, CosIng/PubChem entries show cosmetic peptide use, no CIR/SCCS reproductive findings).
Related ingredients
Frequently asked questions
- tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 hamilelikte güvenli mi?
- No harmonised CLP reproductive classifications (ECHA Annex VI) or CIR/SCCS safety opinions listing reproductive hazard for these cosmetic peptides. Peer‑reviewed and regulatory sources for cosmetic peptides (e.g., oligopeptides/dipeptides/tripeptides used in topical products) do not report teratogenicity or reproductive toxicity; large peptide size and intended topical use make systemic reproductive hazard unlikely (sources: ECHA Annex VI — no harmonised H360/H361, CosIng/PubChem entries show cosmetic peptide use, no CIR/SCCS reproductive findings).
- tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 emzirirken güvenli mi?
- No data indicating reproductive or lactation hazards, no regulatory classifications for breastfeeding risk. Topical cosmetic peptides are large molecules with low dermal penetration in available literature and no evidence of transfer into breast milk or lactation-specific adverse effects in human studies or regulatory assessments (sources: CosIng, PubChem, absence of SCCS/CIR concerns).
- tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 bebek cildi için güvenli mi?
- No evidence of developmental or infant‑specific reproductive toxicity. Peptides used in cosmetics are high molecular weight and generally show negligible dermal absorption; therefore exposure to infants (0–3 yr) from typical topical cosmetic use is expected to be minimal and no infant‑specific hazard is documented. No harmonised CLP flags or published infant toxicity data were found (sources: CosIng, PubChem, PubMed literature absence).
- VeriMom tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 nasıl puanlıyor?
- VeriMom tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte tripeptide-49 oligopeptide-91 dipeptide-19 sh-polypeptide-1 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.